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INTRODUCTION
For anesthetic management during renal trans-
plantation, it is necessary to maintain the blood flow
and function of the transplanted kidney by perform-
ing massive fluid management and stabilizing the
blood pressure from extirpation of the kidney to
be transplanted until the completion of renal ar-
tery anastomosis (1). Recently, simple, less- inva-
sive serial monitors have been developed/improved
with marked advances in circulatory monitoring.
FloTracTM is a less-invasive, arterial pressure-based
cardiac output-monitoring system. The stroke vol-
ume (SV) is estimated based on arterial pressure
waveforms obtained from the radial artery, and mul-
tiplied by the pulse to express the cardiac output
(CO) (2). Furthermore, respiration-related changes
in the SV (stroke volume variation : SVV) are serially
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expressed. SVV may become a parameter of opti-
mized hemodynamics and fluid responsiveness (3).
In addition, the use of a PreSepTM central venous
(CV) oximetry catheter facilitates the serial moni-
toring of central venous oxygen saturation (ScvO2)
(4).
We report anesthetic management for renal
transplantation with a less-invasive circulatory moni-
toring system (Edwards Life Sciences Co., Ltd.,
Irvine, California, U.S.A.) which is used in our hos-
pital.
CASE REPORTS
In November 2010, renal transplantation was
started in our hospital, and performed in 6 patients
(donated kidney : 1 patient, brain death : 1, and liv-
ing : 4, age : 18 to 60 years). The patient back-
ground is shown in Table 1. In the first patient,
fluid/circulatory management was conducted by
connecting a standard arterial line and a standard
CV line. In the second patient, a FloTracTM system
and a standard CV line were used. In the third pa-
tient, a standard arterial line and a PreSepTM CV
oximetry catheter were used. In the fourth and fifth
patients, a FloTracTM system and a PreSepTM CV
oximetry catheter were used. In the latest patient, a
FloTracTM system and PreSepTM CV oximetry cathe-
ter were connected to an EV1000TM Clinical Plat-
form for fluid/circulatory management.
The most recent patient was a 49-year-old male
with chronic renal failure. Living renal transplan-
tation was performed (the donor was his wife).
Complications included ischemic heart disease, hy-
pertension, diabetes, cerebral infarction, and ab-
dominal aortic stenosis. Anesthesia was induced
with remifentanyl and propofol. After achieving mus-
cle relaxation with rocuronium bromide, general an-
esthesia was induced through tracheal intubation.
Subsequently, arterial (FloTracTM) and CV (PreSepTM
CV oximetry catheter) lines were inserted, and con-
nected to an EV1000TM Clinical Platform to start se-
rial monitoring. As a monitoring screen, cockpit or
physio-view monitors were primarily used. The car-
diac output (CO), cardiac index (CI), stroke volume
variation (SVV), stroke volume index (SVI), central
venous oxygen saturation (ScvO2), and systemic
vascular resistance index (SVRI) were comprehen-
sively evaluated, and used as parameters of fluid/
circulatory management. Concerning vital signs af-
ter the start of surgery, blood pressure (BP) was
107/52 mmHg, heart rate (HR) was 71 bpm, CO
was 4.8 L/min, CI was 2.6 L/min/m2, SVV was 6%,
SVI was 4.1 ml/beat/m2, ScvO2 was 71%, and CVP
was 10 mmHg (Fig. 1). To manage the decrease in
blood pressure, phenylephrine and ephedrine were
administered in the absence of fluid loading, and
dopamine therapy at 2 μg/kg/min was started to
maintain the blood pressure until bench surgery.
The kidney was extirpated from the donor 4 hours
after the start of surgery. Fluid loading was initiated
at the start of perfusion. With respect to vital signs
before fluid loading, the BP was 106/52 mmHg, HR
was 108 bpm, CO was 6.9 L/min, CI was 4.0 L/
min/m2, SVV was 22%, and CVP was 10 mmHg un-
der dopamine therapy at 2 μg/kg/min. Establishing
a target SVV of 10% or less, fluid loading at a total of
Table 1. Summary of 6 patients who underwent renal transplantation in Tokushima University hospital
Case 1 2 3 4 5 6
Indication Braindeath Living Living
Donated
kidney Living Living
Age, yr 52 18 46 60 24 49
Weight, kg 55.5 44.5 48.3 65.9 54.8 70.9
Duration of surgery, min 323 465 360 408 361 476
Duration of anesthesia, min 413 540 426 517 444 563
Flo TracTM - + - + + +
PreSepTM - - + + + +
EV1000TM - - - - - +
Fluid until bench surgery/weight, ml/kg 37.8 60.7 31.0 17.5 20.1 16.9
Fluid from bench surgery until initial
urine confirmation/weight, ml/kg - 40.5 33.1 - 40.3 26.8
Total fluid/weight, ml/kg 81.1 139.3 110.7 45.5 100.9 56.4
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approximately 3,000 ml was performed before anas-
tomosis of the renal artery. When the BP, HR, CI,
SVV, SVI, ScvO2, and CVP reached 118/51 mmHg,
107 bpm, 5.6 L/min/m2, 7%, 51 ml/beat/m2, 79%,
and 12 mmHg, respectively, under dopamine ther-
apy at 2.5 μg/kg/min, the vascular clamp was
opened (Fig. 2). The decrease in the blood pres-
sure after opening was slight, and there were slight
changes in the SVV. Initial urine was confirmed
after 40 minutes. A urine volume of 3 ml/kg/hr
was maintained until the completion of surgery.
The hemodynamics at the completion of surgery
were stable : BP, 147/63 mmHg ; HR, 101 bpm ;
CI, 5.3 L/min/m2 ; SVV, 12% ; SVI, 53 ml/beat/m2 ;
ScvO2, 75% ; and CVP, 11 mmHg. The postopera-
tive course was favorable.
DISCUSSION
For anesthetic management during renal trans-
plantation, it is important to promote the trans-
planted kidney function and maintain an adeguate
volume of blood flow in the transplanted kidney to
prevent acute tubular necrosis (1). During renal
transplantation, monitoring is commonly conducted
using electrocardiogram, blood pressure, arterial line,
central venous pressure, end-tidal CO2 (ETCO2),
pulse oximeter, and body temperature. However,
cardiac hypofunction is frequent in patients with re-
nal failure (5, 6). Furthermore, a pulmonary artery
catheter should be inserted, if necessary, to meas-
ure the pulmonary arterial pressure/cardiac output
and perform fluid management, as the number of
diabetic patients has increased (7). However, a pul-
monary artery catheter may cause complications
(8). For circulatory monitoring during renal trans-
plantation, invasive arterial and central venous
pressures have been primarily used. However,
hemodialysis is performed in most patients under-
going renal transplantation, and cardiovascular com-
plications are present ; the central venous pressure
may not be an accurate parameter in some cases
(9).
As a method of circulatory management, there
is the entity of goal-directed therapy (GDT), a so-
calld, “goal-targeting treatment” (10, 11). In particu-
lar, individualized GDT in circulatory management
during anesthesia has recently been used. This re-
fers to patient-matched, SV-/CO-based circulatory/
fluid management in which oxygen supply meet-
ing tissue oxygen demand is maintained, but not the
administration of a specific volume of fluid based
on parameters such as blood pressure, pulse, and
urine volume (12). This therapy reduces the doses
of vasoconstrictors/catecholamines, and reduces the
incidence of postoperative complications, shorten-
ing the admission period (12, 13). The FloTracTM
system is appropriate for individualized GDT. Flow-
based dynamic indices such as the CO, SV, and SVV
are more useful than pressure information-based
management.
Flo TracTM is a less-invasive, arterial pressure-
based cardiac output-monitoring system developed
by Edwards Life Sciences Co., Ltd. In Japan, it
Fig. 1 : Cockpit monitor after the start of surgery
CI ; cardiac index, SVV ; stroke volume variation, SVI ; stroke
volume index, ScvO2 ; central venous oxygen saturation
Fig. 2 : Physio-view monitor at the time the vascular clamp was
opened
CI ; cardiac index, SVV ; stroke volume variation, SVI ; stroke vol-
ume index, ScvO2 ; central venous oxygen saturation, CVP ; cen-
tral venous pressure, SVRI ; systemic vascular resistance index,
PR ; pulse rate, MAP ; maximum arterial pressure
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became clinically available in April 2006. The arterial
pressure-based CO is based on the principle that
the aortic pressure is proportional to the SV, but in-
versely proportional to aortic compliance. Many
studies have reported the accuracy of arterial pres-
sure-based CO monitors (2). Furthermore, SVV is
the most reliable predictor of optimized hemody-
namics and fluid responsiveness. Many studies have
reported its accuracy (3, 14, 15). In addition, the use
of a PreSepTM CV Oximetry Catheter (for adults)
or PediaSatTM Oximetry Catheter (for children) fa-
cilitates the serial monitoring of central venous
oxygen saturation (ScvO2) (4). ScvO2 changes in
parallel to SvO2 (16). As ScvO2 depends on the
CO/hemoglobin level/arterial blood oxygen satu-
ration involved in oxygen transport, as well as me-
tabolism involved in oxygen consumption, continu-
ous monitoring of the oxygen demand/supply bal-
ance is possible (17). Continuous monitoring of
ScvO2 enabled evaluation of the oxygen supply to
tissues to help determine the need for blood trans-
fusion.
We performed circulatory management during re-
nal transplantation using a less-invasive circulatory
monitoring system. In the sixth case, the latest
EV1000TM Clinical Platform was available, facilitating
individualized GDT based on the CO, SVV, SVR,
and ScvO2, in addition to CVP. The establishment
of high-visibility monitors was useful for evaluating
the condition and confirming the effects. The color-
coded image of the target on cockpit monitors fa-
cilitated visual/intuitive assessment of the patient’s
condition. Physio-view monitors made it possible to
understand the interrelationships among the heart,
blood, and vascular system through animation. As
a result, intraoperative management at a fluid vol-
ume smaller than previously used was achieved
(Table 1). For renal transplantation, it is necessary
to restrict fluid management using a vasopressor
until bench kidney surgery and start rapid fluid
loading during anastomosis of the renal artery/vein.
However, most patients with chronic renal failure
do not have any heart reserve to promptly receive
a massive volume of fluid in a relatively short in-
terval during surgery. A close circulatory monitor-
ing system is essential. The use of the EV1000TM
Clinical Platform facilitated appropriate GDT. The
EV1000TM clinical platform (with FloTracTM and
PreSepTM) provided reliable information for the in-
traoperative management of high risk patients dur-
ing renal transplantation without the need for an
invasive pulmonary artery catheter. Goal-directed
hemodynamic and fluid optimization using a less-
invasive circulatory monitoring system may result
in improved outcomes.
CONCLUSION
As there are marked changes in hemodynamics,
the CVP, which has been used as a parameter of
fluid management, is not reliable in renal failure
patients with a high incidence of cardiovascular
complications. Advances in less-invasive circulatory
monitoring with dynamic indices (the EV1000TM
Clinical Platform) may improve the safety of anes-
thetic management during renal transplantation.
In the future, additional monitoring items, such as
the extra-vascular lung water (EVLW) system may
contribute to more comprehensive circulatory man-
agement. In addition, much less-invasive monitor-
ing methods will be developed leading to marked
changes in the renal transplantation area. Anesthe-
siologists must acquire broad, deep knowledge of
the avove methods, including those of the periopera-
tive period.
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